Bosutinib Impurity II | CAS 846023-56-1 - Request Quote
Bosutinib Impurity II
| SZ CAT No: | SZ-B063007 |
| CAS No | 846023-56-1 |
| Mol.F. | C26H31Cl2N5O4 |
| Mol.Wt. | 548.5 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Bosutinib Impurity II is chemically 2-Cyano-N-(2,4-dichloro-5-methoxy phenyl)-3-{4-methoxy-3-[3-(4-methyl piperazin-1-yl)-propoxy]- phenylamino} acrylamide. Bosutinib Impurity II is supplied with detailed characterization data compliant with regulatory guideline. Bosutinib Impurity II can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bosutinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 846023-56-1
Purchase 846023-56-1
Order 846023-56-1
Enquire 846023-56-1
price of 846023-56-1
846023-56-1 Supplier
846023-56-1 Manufacturer
846023-56-1 Exporter
buy high quality Bosutinib Impurity II
Purchase Bosutinib Impurity II
Bosutinib Impurity II suppliers
Bosutinib Impurity II manufacturers
Bosutinib Impurity II price
Order Bosutinib Impurity II
Enquire Bosutinib Impurity II
Bosutinib Impurity II cost
Bosutinib Impurity II Supplier
Bosutinib Impurity II Distributor
Bosutinib Impurity II for Method Validation
Bosutinib Reference Standard
Bosutinib Impurity II for ANDA Filing
Bosutinib Impurity II for Forced Degradation Studies
Bosutinib Impurity II Identification Standards
Bosutinib Impurity II for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.